Therapeutic Alliance and Treatment Outcome

NCT05366998 | Completed

• 1 other identifier: 2021-01-070
• Study Type: observational
• Target: 102
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to inform scientific understanding of the impact of the therapeutic alliance and the transition from inpatient to outpatient care.

Conditions

Therapeutic Alliance

Keywords

Therapeutic Alliance; Treatment Outcome

Outcome Measures

Primary Outcomes (1)

• Change from baseline psychological distress on Brief Symptom Checklist (BSCL, German version) at post-treatment and follow-up

  The BSCL is a 53-item self-report questionnaire that measures psychological distress and symptoms in the last seven days. Each item is rated on a 5-point Likert scale ranging from 0 = "not at all" to 4 = "extremely". The BSCL consists of nine different subscales: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. Moreover, three global indices can be calculated: The Global Severity Index (GSI), providing information on psychological distress, the Positive Symptom Distress Index (PSDI), measuring the intensity of the reported symptoms, and the Positive Symptom Total (PST), indicating the number of present symptoms.

  Baseline, post-treatment (after 6-8 weeks) and follow-up (after 2-4 months)

Secondary Outcomes (7)

• Change from baseline quality of life on short version of the Incongruence Questionnaire (K-INK) at post-treatment and follow-up.

  Baseline, post-treatment (after 6-8 weeks) and follow-up (after 2-4 months)

• Change from baseline quality of life on the short version of the World Health Organization Quality of Life Instrument-Abbreviated Version (EUROHIS-QOL, German version) at post-treatment and follow-up

  Baseline, post-treatment (after 6-8 weeks) and follow-up (after 2-4 months)

• Change from post-treatment therapeutic alliance (inpatient treatment) on the short version of the Working Alliance Inventory - short revised (WAI-SR, German version) at follow-up (outpatient treatment)

  Post-treatment (after 6-8 weeks) and follow-up (after 2-4 months)

• Perceived social support in inpatient setting at post-treatment on the Fellow Patient Social Support (FEPB)

  Post-treatment (after 6-8 weeks)

• Perceived social support in outpatient setting at follow-up on the short version Social Support Questionnaire (F-SozU K-14, German Version)

  follow-up (after 2-4 months)

Other Outcomes (3)

• Perceived experience of the transition from the inpatient to the outpatient setting at post-treatment on a qualitative item

  Post-treatment (after 6-8 weeks)

• Perceived experience of the transition from the inpatient to the outpatient setting at follow-up on qualitative items (Questions in this form are minimally adapted without changing intention due to the limited characters)

  follow-up (after 2-4 months)

• Additional demographics; previous inpatient settings and significant events after the clinic at follow-up on qualitative items

  follow-up (after 2-4 months)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All Patients who are admitted to the PKH. The PKH is a Swiss clinic with 70 beds, located in a rural setting. It treats patients in an inpatient setting for the following psychiatric disorders: depression, burnout, anxiety and psychosomatic disorders.

You may qualify if:

• All patients admitted to in-patient treatment in the private psychiatric clinic Hohenegg (PKH) from November 2021 onwards

Sponsors & Collaborators

• Privatklinik Hohenegg: lead

Study Sites (1)

Privatklinik Hohenegg

Meilen, Canton of Zurich, 8706, Switzerland

Location

Study Officials

• Cosima A. Locher, Dr. phil.

  Privatklinik Hohenegg

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Target Duration: 7 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr. phil.

Study Record Dates

• First Submitted: April 28, 2022
• First Posted: May 10, 2022
• Study Start: November 1, 2021
• Primary Completion: September 30, 2023
• Study Completion: December 4, 2023
• Last Updated: December 6, 2023

Record last verified: 2023-12

Locations

CH (1)